Aryeh Jason

CIK: 0001376960

Aryeh Jason is a corporate insider at LIGAND PHARMACEUTICALS INC (LGND) filing SEC Form 4 transactions. 373 transactions across 9 companies, totaling $5,038,299 in purchases and $37,745,412 in sales. Source: SEC EDGAR.

AI Insider Summary

Jason Aryeh's record spans many biotech names (Ligand/LGND, Nabriva/NABI, Myriad/MYRX) but the standout is direction: code-P open-market purchases of OncoBio (OBIO) — 665 shares at $3.75, 8,971 at $3.90 — genuine buying at a low single-digit price, alongside a Lifecore (LFCR) award.

A Lifecore Biomedical (LFCR) award (25,907 shares) sits alongside as grant-side activity. The P-coded OBIO buys are the signal: a director putting cash into a micro-cap biotech near $3.80.

For readers, Aryeh's accumulation in OBIO is the notable feature against his broad biotech-director backdrop — open-market conviction rather than the disposition norm.

Total Transactions
373
Total Buy Value
$5.04M
Total Sell Value
$37.75M
Net Activity
$-32.71M
Last Transaction
Jun 2026
Companies
9

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Award
Shares
42,553
Price
$4.04
Value
$172K
Type
Sale
Shares
4,500
Price
$250.00
Value
$1.13M
Type
Sale
Shares
500
Price
$250.00
Value
$125K
Type
Award
Shares
2,938
Price
$237.00
Value
$696K
Type
Award
Shares
836
Price
-
Value
-
Type
Award
Shares
25,907
Price
-
Value
-
Type
Purchase
Shares
665
Price
$3.75
Value
$2K
Type
Purchase
Shares
8,971
Price
$3.90
Value
$35K
Type
Exercise
Shares
2,034
Price
-
Value
-
Type
Exercise
Shares
2,034
Price
$69.51
Value
$141K
Type
Sale
Shares
954
Price
$171.92
Value
$164K
Type
Sale
Shares
4,628
Price
$170.96
Value
$791K
Type
Sale
Shares
4,418
Price
$170.41
Value
$753K
Type
Purchase
Shares
1,000
Price
$2.45
Value
$2K
Type
Award
Shares
15,000
Price
-
Value
-
Type
Award
Shares
19,506
Price
-
Value
-
Type
Award
Shares
36,797
Price
-
Value
-
Type
Award
Shares
12,422
Price
-
Value
-
Type
Award
Shares
5,783
Price
-
Value
-
Type
Award
Shares
1,209
Price
-
Value
-